Development of a stable cell manufacturing process based on a novel risk assessment method considering control difficulty
Conference Dates
February 1 – 5, 2026
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Masahiro Kino-oka, "Development of a stable cell manufacturing process based on a novel risk assessment method considering control difficulty" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/23
44.pdf (153 kB)
COinS